• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket

    4/17/24 6:13:57 AM ET
    $ASML
    $CHRO
    $CLNN
    $CXAI
    Industrial Machinery/Components
    Technology
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ASML alert in real time by email

    Shares of INVO Bioscience, Inc. (NASDAQ:INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results.

    The company said quarterly revenue surged 397% year-over-year to $1,381,754, from $278,142 in the year-ago period, according to data from Benzinga Pro.

    INVO Bioscience shares jumped 73.1% to $1.35 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Mobile Global Esports Inc. (NASDAQ:MGAM) shares gained 36.1% to $0.1565 in pre-market trading after falling around 9% on Tuesday. On April 16, Maxim Group analyst Jack Vander Aarde downgraded Mobile Global Esports from Buy to Hold.
    • Chromocell Therapeutics Corporation (NYSE:CHRO) gained 29.1% to $2.35 in pre-market trading after falling around 7% on Tuesday.
    • Clene Inc. (NASDAQ:CLNN) gained 27.9% to $0.3965 in pre-market trading after the company announced Phase 2 VISIONARY-MS long term extension study results at the 2024 American Academy of Neurology Annual Meeting.
    • VIA optronics AG (NYSE:VIAO) shares gained 27.4% to $0.3316 in pre-market trading after dipping over 15% on Tuesday.
    • CXApp Inc. (NASDAQ:CXAI) shares rose 22.3% to $4.78 in pre-market trading after the company announced 24% ARR growth in 2023.
    • Gamer Pakistan Inc (NASDAQ:GPAK) shares gained 21.1% to $0.34 in pre-market trading after gaining 11% on Tuesday.
    • Ucommune International Ltd (NASDAQ:UK) shares gained 19.5% to $2.57 in pre-market trading after gaining 10% on Tuesday.
    • ICZOOM Group Inc. (NASDAQ:IZM) rose 19% to $60.69 in today’s pre-market trading.
    • Pacific Biosciences of California, Inc.(NASDAQ:PACB) gained 12.1% to $1.57 in pre-market trading. PacBio shares dipped more than 50% on Tuesday after the company issued weak guidance.


    Losers

    • Connexa Sports Technologies Inc. (NASDAQ:YYAO) fell 32.3% to $1.42 in pre-market trading.
    • Dynatronics Corporation (NASDAQ:DYNT) fell 19.2% to $0.4442 in pre-market trading after gaining around 48% on Tuesday.
    • Destiny Tech100 Inc. (NASDAQ:DXYZ) fell 17.3% to $35.97 in pre-market trading after gaining around 18% on Tuesday.
    • WiSA Technologies, Inc. (NASDAQ:WISA) fell 15.2% to $5.17 in pre-market trading. WiSA shares jumped over 248% on Tuesday after the company announced a 5-year WiSA E licensing agreement with an HDTV/PTV brand.
    • Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) declined 14.8% to $0.5232 in pre-market trading. Dragonfly Energy shares jumped over 36% on Tuesday after the company reported better-than-expected fourth-quarter EPS results.
    • China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) fell 14.7% to $1.38 pre-market trading. China SXT Pharmaceuticals shares jumped 38% on Tuesday following a post on X from trader Zack Morris mentioning the stock.
    • Trilogy Metals Inc. (NYSE:TMQ) shares fell 14.4% to $0.43 in pre-market trading.
    • Trio Petroleum Corp. (NYSE:TPET) fell 12.8% to $0.4250 pre-market trading after dipping over 22% on Tuesday.
    • J B Hunt Transport Services Inc (NASDAQ:JBHT) shares fell 6% to $172.00 in pre-market trading after the company missed first-quarter revenue and EPS estimates.
    • ASML Holding N.V. (NASDAQ:ASML) shares declined 4.9% to $929.00 in pre-market trading after the company reported worse-than-expected first-quarter results and issued second-quarter guidance.

     

    Now Read This: Investor Optimism Decreases; Dow Ends 6-Session Losing Streak

     

    Get the next $ASML alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASML
    $CHRO
    $CLNN
    $CXAI

    CompanyDatePrice TargetRatingAnalyst
    Trilogy Metals Inc.
    $TMQ
    2/20/2026Hold → Buy
    TD Cowen
    ASML Holding N.V. New York Registry Shares
    $ASML
    1/29/2026Equal Weight → Overweight
    Barclays
    ASML Holding N.V. New York Registry Shares
    $ASML
    1/15/2026Outperform
    RBC Capital Mkts
    J.B. Hunt Transport Services Inc.
    $JBHT
    1/8/2026$221.00Buy → Neutral
    Citigroup
    J.B. Hunt Transport Services Inc.
    $JBHT
    1/8/2026$240.00Neutral → Positive
    Susquehanna
    ASML Holding N.V. New York Registry Shares
    $ASML
    1/5/2026$1528.00Mkt Perform → Outperform
    Bernstein
    J.B. Hunt Transport Services Inc.
    $JBHT
    12/11/2025$227.00Hold → Buy
    Deutsche Bank
    ASML Holding N.V. New York Registry Shares
    $ASML
    11/7/2025Neutral → Buy
    Rothschild & Co Redburn
    More analyst ratings

    $ASML
    $CHRO
    $CLNN
    $CXAI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Matlin David J bought $216,664 worth of shares (33,333 units at $6.50), increasing direct ownership by 7% to 477,824 units (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    1/13/26 2:48:54 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP of ICS Mcgee Eric bought $161,553 worth of shares (1,148 units at $140.76) (SEC Form 4)

    4 - HUNT J B TRANSPORT SERVICES INC (0000728535) (Issuer)

    8/8/25 10:29:09 AM ET
    $JBHT
    Trucking Freight/Courier Services
    Industrials

    EVP and COO Hobbs Nicholas bought $399,746 worth of shares (3,038 units at $131.58), increasing direct ownership by 3% to 93,356 units (SEC Form 4)

    4 - HUNT J B TRANSPORT SERVICES INC (0000728535) (Issuer)

    4/25/25 4:25:04 PM ET
    $JBHT
    Trucking Freight/Courier Services
    Industrials

    $ASML
    $CHRO
    $CLNN
    $CXAI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Trilogy Metals upgraded by TD Cowen

    TD Cowen upgraded Trilogy Metals from Hold to Buy

    2/20/26 8:21:03 AM ET
    $TMQ
    Precious Metals
    Basic Materials

    ASML upgraded by Barclays

    Barclays upgraded ASML from Equal Weight to Overweight

    1/29/26 6:57:57 AM ET
    $ASML
    Industrial Machinery/Components
    Technology

    RBC Capital Mkts initiated coverage on ASML

    RBC Capital Mkts initiated coverage of ASML with a rating of Outperform

    1/15/26 8:34:58 AM ET
    $ASML
    Industrial Machinery/Components
    Technology

    $ASML
    $CHRO
    $CLNN
    $CXAI
    SEC Filings

    View All

    SEC Form 10-K filed by J.B. Hunt Transport Services Inc.

    10-K - HUNT J B TRANSPORT SERVICES INC (0000728535) (Filer)

    2/24/26 2:47:27 PM ET
    $JBHT
    Trucking Freight/Courier Services
    Industrials

    Clene Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Clene Inc. (0001822791) (Filer)

    2/24/26 8:01:51 AM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Trilogy Metals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Trilogy Metals Inc. (0001543418) (Filer)

    2/23/26 11:31:05 AM ET
    $TMQ
    Precious Metals
    Basic Materials

    $ASML
    $CHRO
    $CLNN
    $CXAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Mclaughlin Vallerie

    4 - Clene Inc. (0001822791) (Issuer)

    2/20/26 4:05:57 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Wilcox Reed N

    4 - Clene Inc. (0001822791) (Issuer)

    2/20/26 4:05:22 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Mosca Alison

    4 - Clene Inc. (0001822791) (Issuer)

    2/20/26 4:04:47 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASML
    $CHRO
    $CLNN
    $CXAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research

    MENLO PARK, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced a collaboration with DNAstack to power the world's first global federated dataset of HiFi whole genome sequencing data. Through the HiFi Solves Global Consortium, the collaboration enables secure international research — allowing genomic insights to travel across borders while sensitive data remains under institutional control. Participating institutions connect HiFi whole genome sequencing data and associated metadata within a highly secure federated environment. Hosted by DNAstack and accessible at https://hifisolves.org, the platfor

    2/24/26 9:05:00 AM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts

    Operating capital runway sufficient into the fourth quarter of 2026 In-person Type C FDA meeting scheduled by end of the first quarter of 2026 to discuss the latest CNM-Au8 data submitted in late 2025Anticipated submission of a New Drug Application (NDA) to FDA for CNM-Au8 via an accelerated regulatory pathway in the second quarter of 2026Potential for FDA acceptance of this NDA and issuance of a Prescription Drug User Fee Act (PDUFA) date in the second half of 2026 SALT LAKE CITY, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene" or the "Company") and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical com

    2/24/26 8:00:00 AM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream

    MIAMI, Feb. 24, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 90th Emerging Growth Conference on February 25 & 26, 2026. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1 - WednesdayFebruary 25, 2026 8:45Virtual Lobby opens.Register for the Conference. If you already registered, go

    2/24/26 7:00:00 AM ET
    $AEMD
    $ASPI
    $CLNN
    Medical/Dental Instruments
    Health Care
    Major Chemicals
    Industrials

    $ASML
    $CHRO
    $CLNN
    $CXAI
    Financials

    Live finance-specific insights

    View All

    Company retires remaining Outstanding Convertible Investments

    Malibu, CA, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Trio Petroleum Corp (NYSE American: "TPET", "Trio" or the "Company"), a California oil and gas company, announced that as of February 13 ,2026, convertible promissory notes with an aggregate principal of $1.2 million (the "Notes") had been fully converted into shares of Trio common stock. The Notes were issued to three institutional investors (the "Investors") in August 2025, in connection with a private placement of convertible debt financing. The shares of common stock issued to the Investors upon their conversions of the Notes were all registered for resale by the Company in a registration statement filed by the Company with the Securities a

    2/18/26 8:00:00 AM ET
    $TPET
    Oil & Gas Production
    Energy

    PacBio Announces Fourth Quarter and Full Year 2025 Financial Results

    MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) today announced financial results for the quarter and fiscal year ended December 31, 2025. Fourth quarter and full year results:  Q4 2025Q4 2024FY 2025FY 2024Revenue (in millions)$44.6$39.2$160.0$154.0Consumable revenue (in millions)$21.6$18.8$82.0$70.3Instrument revenue (in millions)$17.3$15.3$53.8$65.8Service and other revenue (in millions)$5.7$5.1$24.2$17.9RevioTM system placements21236197VegaTM system placements4271407Annualized Revio pull-through per system~$242,000~$240,000~$233,000~$252,000Ending cash, cash equivalents, and investments(in millions)$279.5$389.9   Gross margin, operating expenses, net inco

    2/12/26 4:05:00 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    ASML reports €32.7 billion total net sales and €9.6 billion net income in 2025

    ASML reports €32.7 billion total net sales and €9.6 billion net income in 2025ASML expects 2026 total net sales to be between €34 billion and €39 billion, with a gross margin between 51% and 53% VELDHOVEN, the Netherlands, January 28, 2026 – Today, ASML Holding NV (ASML) has published its 2025 fourth-quarter and full-year results. Q4 total net sales of €9.7 billion, gross margin of 52.2%, net income of €2.8 billionQuarterly net bookings in Q4 of €13.2 billion of which €7.4 billion is EUV2025 total net sales of €32.7 billion, gross margin of 52.8%, net income of €9.6 billionBacklog at the end of 2025 of €38.8 billionASML expects Q1 2026 total net sales between €8.2 billion and €8.9 billion

    1/28/26 1:00:00 AM ET
    $ASML
    Industrial Machinery/Components
    Technology

    $ASML
    $CHRO
    $CLNN
    $CXAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Pacific Biosciences of California Inc.

    SC 13G - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (0001299130) (Subject)

    11/26/24 8:27:01 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13D/A filed by Dragonfly Energy Holdings Corp.

    SC 13D/A - Dragonfly Energy Holdings Corp. (0001847986) (Subject)

    11/21/24 6:10:38 PM ET
    $DFLI
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G filed by Pacific Biosciences of California Inc.

    SC 13G - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (0001299130) (Subject)

    11/14/24 5:52:54 PM ET
    $PACB
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ASML
    $CHRO
    $CLNN
    $CXAI
    Leadership Updates

    Live Leadership Updates

    View All

    J.B. Hunt Joins the Triumph Network

    Triumph (NYSE:TFIN), a financial and technology company focused on modernizing and simplifying freight transactions, today announced that J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT) has joined the Triumph Network. J.B. Hunt, one of the largest supply chain solutions providers in North America, will adopt Triumph's advanced automated payment solution to accelerate and streamline carrier payment cycles. "J.B. Hunt's reputation as an innovator in transportation and logistics, combined with their commitment to embracing technology, makes them a true leader in our industry," said Triumph founder and chief executive officer, Aaron P. Graft. "Their decision to join the Triumph Network und

    1/22/26 4:07:00 PM ET
    $JBHT
    $TFIN
    Trucking Freight/Courier Services
    Industrials
    Major Banks
    Finance

    ICZOOM Group Inc. Appoints Hantao Cui as Chief Strategy Officer and a Director

    Hong Kong, Nov. 12, 2025 (GLOBE NEWSWIRE) -- ICZOOM Group Inc. (NASDAQ:IZM) (the "Company"), a B2B electronic component products e-commerce platform, today announced the appointment of Ms. Hantao Cui as Chief Strategy Officer and a Director of the Company, effective November 11, 2025. Ms. Duanrong Liu will step down from her position as the Chief Operating Officer of the Company, effective November 11, 2025. Hantao Cui has served as Chief Executive Officer of Matrix Science & Technology (Shanghai) Limited since January 2011, where she leads a total solution provider specializing in custom-designed transportation packaging for industrial products. Ms. Cui also serves as a director at Strea

    11/12/25 8:00:00 AM ET
    $IZM
    Consumer Electronics/Video Chains
    Consumer Discretionary

    ASML appoints next Chief Technology Officer

    ASML appoints next Chief Technology Officer Marco Pieters appointed ASML Chief Technology Officer ASML Supervisory Board intends to reappoint CFO Roger Dassen and COO Frédéric Schneider-Maunoury, and to appoint CTO Marco Pieters to the Board of Management as of the April 2026 AGM VELDHOVEN, The Netherlands, October 9, 2025 – ASML Holding NV (ASML) today announced the appointment of Marco Pieters as Executive Vice President and Chief Technology Officer, reporting to President and Chief Executive Officer, Christophe Fouquet. With over 25 years of experience at ASML, most recently as Executive Vice President for the product area Applications, Pieters has a strong track record in technology l

    10/9/25 2:00:00 AM ET
    $ASML
    Industrial Machinery/Components
    Technology